Neurodevelopmental Outcomes in Children with Congenital Heart Disease: Ten Years After the American Heart Association

Trisha Patel1, Dawn Ilardi1, Lazaros Kochilas1

  • 1Emory University School of Medicine, 1405 Clifton Road, Atlanta, GA 30322, USA; Children's Healthcare of Atlanta, 1400 Tullie Road, Atlanta, GA 30329, USA.

Insights

Children with congenital heart disease (CHD) face lifelong neurodevelopmental challenges. Early evaluations are crucial but often hindered by various barriers, necessitating improved access to care.

Area of Science:

  • Pediatric Cardiology
  • Neurodevelopmental Pediatrics
  • Child Psychology

Background:

  • Congenital heart disease (CHD) presents significant risks for neurodevelopmental issues even before birth.
  • Neurodevelopmental concerns in CHD patients are compounded by medical treatments and socioeconomic factors.
  • Individuals with CHD experience persistent challenges in cognitive, academic, psychological, and quality-of-life domains.

Purpose of the Study:

  • To highlight the critical need for early and repeated neurodevelopmental evaluations in children with CHD.
  • To identify the multifaceted barriers hindering the completion of these essential evaluations.
  • To advocate for future research focused on CHD-specific programs and access to care.

Main Methods:

  • This study is a review of existing literature and clinical observations regarding neurodevelopmental outcomes in CHD.
  • Analysis of factors contributing to neurodevelopmental deficits in the CHD population.
  • Identification of environmental, provider, patient, and family-level obstacles to neurodevelopmental assessment.

Main Results:

  • Children with CHD are predisposed to neurodevelopmental deficits from prenatal stages.
  • Lifelong cognitive, academic, and psychosocial difficulties are common in individuals with CHD.
  • Significant barriers impede the consistent and comprehensive neurodevelopmental evaluation of CHD patients.

Conclusions:

  • Early and ongoing neurodevelopmental assessment is vital for accessing necessary support services for children with CHD.
  • Addressing the identified barriers is essential to improve access to neurodevelopmental evaluations.
  • Future research should focus on evaluating the efficacy of CHD-specific neurodevelopmental programs and overcoming access challenges.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
20
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
24
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.4K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
22
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.7K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
15